As the broader stock rally broadens to some of the more “boring” corners of the market, it's the higher-yielding dividend plays that could stand to move higher from current levels. Undoubtedly, a b...

CVS Group (AIM:CVSG), the veterinary service provider, has been downgraded to "sector perform" by analysts at RBC following the CMA's review of the industry. The group's price target has also been ...

CVS Group (AIM:CVSG) PLC has said proposals are already available to address competition concerns in Britain's veterinary sector, after news of a probe stripped a quarter of its value on Tuesday. P...

CVS Health is a lot more than just a chain of retail pharmacies. Aetna, one of America's largest health insurance companies, is a CVS Health subsidiary.

CVS Health reported solid full-year results for fiscal 2023, but already had to lower its guidance for fiscal 2024. During the 2023 investor day, CVS also lowered its long-term guidance but is stil...

CVS Health and the healthcare services sector are facing numerous challenges in 2024, including cyber attacks, regulatory scrutiny, declining COVID-related sales, and lower CMS rates. The company i...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) an...

CVS Health's strong position and comprehensive healthcare operations make it a solid long-term pick. Fiverr should benefit from the growing gig economy, a trend that has accelerated in recent years.

CVS Health (CVS) reachead $74.30 at the closing of the latest trading day, reflecting a -0.05% change compared to its last close.

CVS Health Corporation (NYSE:CVS ) 45th Annual Raymond James Institutional Investors Conference Transcript March 5, 2024 9:50 AM ET Executives Tom Cowhey - Executive Vice President and CFO Analysts...

CVS Health's (CVS) new launch will enable early detection of heart arrhythmia and can help mitigate symptoms and more severe complications.

CVS and Walgreens will begin selling the abortion pill mifepristone at pharmacies across select states in the coming weeks, as the Supreme Court gears up to hear oral arguments about the drug at th...

He added that Walgreens was “not going to dispense in states where the laws are unclear” -- such as in Kansas, Montana and Wyoming, where abortion laws are being challenged and are currently in lim...

CVS and Walgreens have received certification from the FDA to dispense the commonly used mifepristone at their retail pharmacies, spokespeople told CNBC.

CVS and Walgreens, the two largest U.S. pharmacy chains, will start selling abortion pill mifepristone at their stores in several states this month.